Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Greening, AP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Whittle, AT; Davis, M; Shovlin, CL; Ganly, PS; Haslett, C; Greening, AP
      Alveolar macrophage activity and the pulmonary complications of haematopoietic stem cell transplantation

      THORAX
    2. Crompton, GK; Sanderson, R; Dewar, MH; Matusiewicz, SP; Ning, ACWS; Jamieson, AH; McLean, A; Greening, AP
      Comparison of Pulmicort (R) pMDI plus Nebuhaler (R) and Pulmicort (R) Turbuhaler (R) in asthmatic patients with dysphonia

      RESPIRATORY MEDICINE
    3. Simpson, AJ; Matusiewicz, SP; Greening, AP; Crompton, GK
      Pet ownership and asthma morbidity

      RESPIRATORY MEDICINE
    4. Ho, LP; Wood, FT; Robson, A; Innes, JA; Greening, AP
      The current single exhalation method of measuring exhaled nitric oxide is affected by airway calibre

      EUROPEAN RESPIRATORY JOURNAL
    5. Cunningham, S; McColm, JR; Ho, LP; Greening, AP; Marshall, TG
      Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis

      EUROPEAN RESPIRATORY JOURNAL
    6. Simpson, AJ; Matusiewicz, SP; Brown, PH; McCall, IA; Innes, JA; Greening, AP; Crompton, GK
      Emergency pre-hospital management of patients admitted with acute asthma

      THORAX
    7. Ho, LP; Wood, FT; Robson, A; Innes, JA; Greening, AP
      Atopy influences exhaled nitric oxide levels in adult asthmatics

      CHEST
    8. Ho, LP; Faccenda, J; Innes, JA; Greening, AP
      Expired hydrogen peroxide in breath condensate of cystic fibrosis patients

      EUROPEAN RESPIRATORY JOURNAL
    9. Bollert, FGE; Paton, JY; Marshall, TG; Calvert, J; Greening, AP; Innes, JA
      Recombinant DNase in cystic fibrosis: a protocol for targeted introductionthrough n-of-1 trials

      EUROPEAN RESPIRATORY JOURNAL
    10. Whittle, AT; Davis, M; Johnson, PRE; Leonard, RCF; Greening, AP
      The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia

      BONE MARROW TRANSPLANTATION
    11. Cushley, MJ; Davison, AG; du Bois, RM; Egan, J; Flower, CDR; Gibson, GJ; Greening, AP; Ibrahim, NBN; Johnston, IDA; Mitchell, DM; Pickering, CAC
      The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults

      THORAX
    12. RODGERS HC; LIDDLE K; NIXON SJ; INNES JA; GREENING AP
      TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES IN CYSTIC-FIBROSIS - COMPLICATIONS AND PATIENTS OPINIONS

      The European respiratory journal
    13. Ho, LP; Innes, JA; Greening, AP
      Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis

      EUROPEAN RESPIRATORY JOURNAL
    14. HO LP; INNES JA; GREENING AP
      NITRITE LEVELS IN BREATH CONDENSATE OF PATIENTS WITH CYSTIC-FIBROSIS IS ELEVATED IN CONTRAST TO EXHALED NITRIC-OXIDE

      Thorax
    15. ROSSI AG; HASLETT C; HIRANI N; GREENING AP; RAHMAN I; METZ CN; BUCALA R; DONNELLY SC
      HUMAN CIRCULATING EOSINOPHILS SECRETE MACROPHAGE-MIGRATION INHIBITORYFACTOR (MIF) - POTENTIAL ROLE IN ASTHMA

      The Journal of clinical investigation
    16. PORTEOUS DJ; DORIN JR; MCLACHLAN G; DAVIDSONSMITH H; DAVIDSON H; STEVENSON BJ; CAROTHERS AD; WALLACE WAH; MORALEE S; HOENES C; KALLMEYER G; MICHAELIS U; NAUJOKS K; HO LP; SAMWAYS JM; IMRIE M; GREENING AP; INNES JA
      EVIDENCE FOR SAFETY AND EFFICACY OF DOTAP CATIONIC LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS

      Gene therapy
    17. FROEBEL KS; BOLLERT FGE; JELLEMA J; BIRD AG; GREENING AP
      IMMUNODEFICIENCY IN NONTUBERCULOUS MYCOBACTERIAL DISEASE

      Respiratory medicine
    18. GREENING AP
      CLINICAL ISSUES IN THE TREATMENT OF ADULT ASTHMA

      Respiratory medicine
    19. HO LP; SAMWAYS JM; PORTEOUS DJ; DORIN DJ; CAROTHERS A; GREENING AP; INNES JA
      CORRELATION BETWEEN NASAL POTENTIAL DIFFERENCE MEASUREMENTS, GENOTYPEAND CLINICAL CONDITION IN PATIENTS WITH CYSTIC-FIBROSIS

      The European respiratory journal
    20. BOLLERT FGE; MATUSIEWICZ SP; DEWAR MH; BROWN GM; MCLEAN A; GREENING AP; CROMPTON GK
      COMPARATIVE EFFICACY AND POTENCY OF IPRATROPIUM VIA TURBUHALER(R) ANDPRESSURIZED METERED-DOSE INHALER IN REVERSIBLE AIR-FLOW OBSTRUCTION

      The European respiratory journal
    21. GREENING AP
      PLACE OF LONG-ACTING BETA-AGONISTS IN ASTHMA NOT CONTROLLED BY CORTICOSTEROIDS

      CLINICAL IMMUNOTHERAPEUTICS
    22. MCLACHLAN G; HO LP; DAVIDSONSMITH H; SAMWAYS J; DAVIDSON H; STEVENSON BJ; CAROTHERS AD; ALTON EWFW; MIDDLETON PG; SMITH SN; KALLMEYER G; MICHAELIS U; SEEBER S; NAUJOKS K; GREENING AP; INNES JA; DORIN JR; PORTEOUS DJ
      LABORATORY AND CLINICAL-STUDIES IN SUPPORT OF CYSTIC-FIBROSIS GENE-THERAPY USING PCMV-CFTR-DOTAP

      Gene therapy
    23. BARNES PJ; GREENING AP; CROMPTON GK
      GLUCOCORTICOID RESISTANCE IN ASTHMA

      American journal of respiratory and critical care medicine
    24. WILLIAMSON IJ; MATUSIEWICZ SP; BROWN PH; GREENING AP; CROMPTON GK
      FREQUENCY OF VOICE PROBLEMS AND COUGH IN PATIENTS USING PRESSURIZED AEROSOL INHALED STEROID PREPARATIONS

      The European respiratory journal
    25. BROWN PH; NING ACWS; GREENING AP; MCLEAN A; CROMPTON GK
      PEAK INSPIRATORY FLOW-THROUGH TURBUHALER(R) IN ACUTE ASTHMA

      The European respiratory journal
    26. BOLLERT FGE; WATT B; GREENING AP; CROMPTON GK
      NONTUBERCULOUS PULMONARY INFECTIONS IN SCOTLAND - A CLUSTER IN LOTHIAN

      Thorax
    27. MATUSIEWICZ SP; FERGUSSON RJ; GREENING AP; CROMPTON GK; BURNS SM
      PNEUMOCYSTIS-CARINII IN BRONCHOALVEOLAR LAVAGE FLUID AND BRONCHIAL WASHINGS

      BMJ. British medical journal
    28. GREENING AP
      CLINICAL-TRIALS OF HIGH-DOSE FLUTICASONE PROPIONATE

      Respiratory medicine
    29. GREENING AP; IND PW; NORTHFIELD M; SHAW G
      ADDED SALMETEROL VERSUS HIGHER-DOSE CORTICOSTEROID IN ASTHMA PATIENTSWITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID

      Lancet
    30. INNES JA; GREENING AP; WEBB K
      HIGH-STRENGTH PANCREATIC-ENZYMES

      Lancet
    31. WALLACE WAH; ROBERTS SN; CALDWELL H; THORNTON E; GREENING AP; LAMB D; HOWIE SEM
      CIRCULATING ANTIBODIES TO LUNG PROTEIN(S) IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITIS

      Thorax
    32. MACKAY TW; WALLACE WAH; HOWIE SEM; BROWN PH; GREENING AP; CHURCH MK; DOUGLAS NJ
      ROLE OF INFLAMMATION IN NOCTURNAL ASTHMA

      Thorax
    33. BROWN P; GREENING AP; CROMPTON GK
      HYPOTHALAMO-PITUITARY-ADRENAL AXIS SUPPRESSION IN ASTHMATICS - REPLY

      Respiratory medicine
    34. MATUSIEWICZ SP; WILLIAMSON IJ; SIME PJ; BROWN PH; WENHAM PR; CROMPTON GK; GREENING AP
      PLASMA LACTATE-DEHYDROGENASE - A MARKER OF DISEASE-ACTIVITY IN CRYPTOGENIC FIBROSING ALVEOLITIS AND EXTRINSIC ALLERGIC ALVEOLITIS

      The European respiratory journal
    35. GOVAN JRW; BROWN PH; MADDISON J; DOHERTY CJ; NELSON JW; DODD M; GREENING AP; WEBB AK
      EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT INCYSTIC-FIBROSIS

      Lancet
    36. BROWN PH; MATUSIEWICZ SP; SHEARING C; TIBI L; GREENING AP; CROMPTON GK
      SYSTEMIC EFFECTS OF HIGH-DOSE INHALED STEROIDS - COMPARISON OF BECLOMETHASONE DIPROPIONATE AND BUDESONIDE IN HEALTHY-SUBJECTS

      Thorax
    37. NELSON JW; BUTLER SL; BROWN PH; GREENING AP; GOVAN JRW
      SERUM IGG AND SPUTUM IGA ANTIBODY TO CORE LIPOPOLYSACCHARIDE ANTIGEN FROM PSEUDOMONAS-CEPACIA IN PATIENTS WITH CYSTIC-FIBROSIS

      Journal of Medical Microbiology
    38. TUOHY MB; BAIN MH; GREENING AP
      HYPOXIA PRIMES RAT ALVEOLAR MACROPHAGES FOR ENHANCED STIMULATED RELEASE OF HYDROGEN-PEROXIDE

      The American review of respiratory disease
    39. BROWN PH; MATUSIEWICZ SP; WALLACE WAH; HOWIE SEM; RAMAGE E; CROMPTON GK; LAMB DL; GREENING AP
      BRONCHIAL INFLAMMATION IN CORTICOSTEROID-SENSITIVE (CS) AND CORTICOSTEROID-RESISTANT (CR) ASTHMA

      The American review of respiratory disease
    40. MATUSIEWICZ SP; WALLACE WAH; HOWIE SEM; GREENING AP
      BLOOD LYMPHOCYTE AND MONOCYTE CELL-SURFACE ACTIVATION MARKERS IN PATIENTS WITH MODERATE SEVERE SYMPTOMATIC ASTHMA/

      The American review of respiratory disease
    41. MATUSIEWICZ SP; BROWN PH; CROMPTON GK; GREENING AP
      SAFETY OF FIBEROPTIC BRONCHOSCOPY FOR RESEARCH IN PATIENTS WITH SEVERE CHRONIC ASTHMA

      The American review of respiratory disease
    42. MATUSIEWICZ SP; BROWN PH; GORDON M; GREENING AP
      ALVEOLAR MACROPHAGE CYTOKINE GENERATION IN SEVERE CHRONIC BRONCHIAL-ASTHMA

      The American review of respiratory disease
    43. MATUSIEWICZ SP; DEWAR M; HOWIE SEM; GREENING AP
      SALMETEROL THERAPY FOR SEVERE NOCTURNAL ASTHMA DOES NOT INFLUENCE BLOOD LYMPHOCYTE AND MONOCYTE CELL-SURFACE ACTIVATION

      The American review of respiratory disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 20:11:51